Hyperkalemia 3: Clinical Trial Update for Newer Therapeutic Options to Treat Hyperkalemia

エピソード

A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center
6 8月· AcademicCME Podcast
This activity was supported by an educational grant from argenx US Inc. Please go to ⁠⁠academiccme.com/MGInfusionsCE⁠ and complete the evaluation to receive your CE/CME Credit.Credit is available through August 5, 2025.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment
19 6月· AcademicCME Podcast
This activity was supported by an educational grant from Travere Therapeutics. Please go to https://academiccme.com/CKDCE1/ and complete the evaluation to receive your CE/CME Credit.Credit is available through March 24, 2025.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
エピソードを見逃しましたか？

フィードを更新するにはここをクリックしてください。
VTE and Anticoagulation - Guideline Updates for 2024
25 4月· AcademicCME Podcast
This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE4/ and complete the evaluation to receive your CE/CME Credit.Credit is available through March 24, 2025.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE
26 3月· AcademicCME Podcast
This activity was supported by an educational grant from Bristol Myers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE3/ and complete the evaluation to receive your CE/CME Credit.Credit is available through March 24, 2025.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE
10 1月· AcademicCME Podcast
This activity was supported by an educational grant from BristolMyers Squibb and Pfizer Alliance. Please go to https://academiccme.com/VTECE/ andcomplete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Part 1: Advances in Patient-Actuated Treatment for PSVT
16 8月 2023· AcademicCME Podcast
This activity was supported by an educational grant from Milestone Pharmaceuticals. Please go to academiccme.com/PSVTpodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Part 2: Advances in Patient-Actuated Treatment for PSVT
16 8月 2023· AcademicCME Podcast
This activity was supported by an educational grant from Milestone Pharmaceuticals. Please go to academiccme.com/PSVTpodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer
9 1月 2023· AcademicCME Podcast
Please go to academiccme.com/ovariancancer/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies
3 1月 2023· AcademicCME Podcast
Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Hyperkalemia 3: Clinical Trial Update for Newer Therapeutic Options to Treat Hyperkalemia
3 1月 2023· AcademicCME Podcast
Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Hyperkalemia Part 2: Understand the limitations and impact of plant-based diets and potassium restricted diets on the incidence and severity of hyperkalemia
3 1月 2023· AcademicCME Podcast
Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Hyperkalemia Part 1: Review the Science of Recurrent Hyperkalemia, Including Relationships Between Dietary Potassium Intake, Serum Potassium, and Patient Morbidities
3 1月 2023· AcademicCME Podcast
Please go to academiccme.com/hyperkalemiapodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Avances en el tratamiento de la ERC con inhibidores de SGLT2 en pacientes con y sin diabetes: el ensayo EMPA-KIDNEY
27 12月 2022· AcademicCME Podcast
Vaya a https://academiccme.com/empa-kidney-es-podcast/ y complete la evaluación para recibir su crédito CE/CME.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Kombinationstherapie der chronischen Nierenerkrankung: Die EMPA-Kidney Studie
22 12月 2022· AcademicCME Podcast
Bitte gehen Sie zu https://academiccme.com/empa-kidney-de-podcast/ und füllen Sie die Bewertung aus, um Ihren CE/CME Credit zu erhalten.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
EMPA-Kidney: la révolution de la néphroprotection par les inhibiteurs SGLT-2 est là
21 12月 2022· AcademicCME Podcast
Veuillez vous rendre sur https://academiccme.com/empa-kidney-fr-podcast/ et compléter l'évaluation pour recevoir votre crédit CE/CME.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
Advances in Slowing the Progression of CKD with SGLT2 Inhibitors
15 12月 2022· AcademicCME Podcast
Please go to https://academiccme.com/empa-kidney-podcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
NTM Series Ep. 5: Evaluation of Clinical Data on NTM‐LD Therapeutics and Management
13 12月 2022· AcademicCME Podcast
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
NTM Series Ep. 4: Diagnostic Stratgies and Long-Term Management of Patients with NTM-LD
22 11月 2022· AcademicCME Podcast
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
NTM Series Ep. 3: Clinical Trial Update: ATS 2022
29 9月 2022· AcademicCME Podcast
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
NTM Series Ep. 2: Improving Adherence and Outcomes While Reducing the Risk of Drug-Related Toxicity
3 8月 2022· AcademicCME Podcast
Please go to https://academiccme.com/ntmpodcast/ and complete the evaluation to receive your CE/CME Credit.
- 聴くもう一度聞く続ける再生中...
- 後で聞く後で聞く
もっと表示する

エピソード

A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

IgA Nephropathy - Epidemiology, Clinical Presentation, Pathophysiology, and Approach to Treatment

VTE and Anticoagulation - Guideline Updates for 2024

Shared Decision-Making & Patient Education to Promote Adherence to DOACs & Continuity of Care in VTE

Review of Clinical Trial and Real-World Data for DOAC and other Anticoagulation Therapeutics for VTE

Part 1: Advances in Patient-Actuated Treatment for PSVT

Part 2: Advances in Patient-Actuated Treatment for PSVT

Applying Poly (ADP-ribose) Polymerase (PARP) Inhibitors to Maintenance Treatment Plans to Improve Outcomes for Patients with Advanced Ovarian Cancer

Hyperkalemia 4: A Multidisciplinary and Interprofessional Approach to Best Treat Hyperkalemia and Associated Comorbidities – Challenging Patient Case Studies

Hyperkalemia Part 2: Understand the limitations and impact of plant-based diets and potassium restricted diets on the incidence and severity of hyperkalemia

Hyperkalemia Part 1: Review the Science of Recurrent Hyperkalemia, Including Relationships Between Dietary Potassium Intake, Serum Potassium, and Patient Morbidities

Avances en el tratamiento de la ERC con inhibidores de SGLT2 en pacientes con y sin diabetes: el ensayo EMPA-KIDNEY

Kombinationstherapie der chronischen Nierenerkrankung: Die EMPA-Kidney Studie

EMPA-Kidney: la révolution de la néphroprotection par les inhibiteurs SGLT-2 est là

Advances in Slowing the Progression of CKD with SGLT2 Inhibitors

NTM Series Ep. 5: Evaluation of Clinical Data on NTM‐LD Therapeutics and Management

NTM Series Ep. 4: Diagnostic Stratgies and Long-Term Management of Patients with NTM-LD

NTM Series Ep. 3: Clinical Trial Update: ATS 2022

NTM Series Ep. 2: Improving Adherence and Outcomes While Reducing the Risk of Drug-Related Toxicity